Apr.13 -- Mayo Clinic Vaccine Research Group Director Dr. Gregory Poland says the pause in the distribution of the Johnson & Johnson Covid-19 vaccine is "stellar evidence" of vaccine safety surveillance. He speaks on "Bloomberg Markets."